Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banna

Showing results (901-910 of 991) with videos related to

Pageof 100
Sort By:
NPJ Precision Oncology|July 2, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI studySara Elena Rebuzzi, Vanja Miskovic, Giuseppe Fornarini, et al.
Future Oncology (London, England)|March 20, 2014
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community settingGiuseppe Procopio, Lisa Derosa, Angela Gernone, et al.
Plos One|November 14, 2019
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approachAlessio Bruni, Niccolò Giaj-Levra, Patrizia Ciammella, et al.
Tumori|July 14, 2015
Oral chemotherapy and patient perspective in solid tumors: a national survey by the Italian association of medical oncologyGaetano Aurilio, Stefania Gori, Franco Nolè, et al.
Epilepsy & Behavior : E&B|February 8, 2018
An objective score to identify psychogenic seizures based on age of onset and historyWesley T Kerr, Emily A Janio, Chelsea T Braesch, et al.
Expert Review of Anticancer Therapy|April 5, 2023
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?Matilde Corianò, Diana Giannarelli, Giulia Scartabellati, et al.
AAPS Pharmscitech|November 18, 2020
Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo StudyFatma I Abo El-Ela, Khaled H Hussein, Hossny A El-Banna, et al.
Msphere|February 23, 2024
Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participantsPinki Dash, Al Hakim, Aklima Akter, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO NetworkGiuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2022
Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinomaGuru P Sonpavde, Cora N Sternberg, Yohann Loriot, et al.
Pageof 100

Showing results (901-910 of 991) with videos related to

Sort By:
Pageof 100
NPJ Precision Oncology|July 2, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI studySara Elena Rebuzzi, Vanja Miskovic, Giuseppe Fornarini, et al.
Future Oncology (London, England)|March 20, 2014
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community settingGiuseppe Procopio, Lisa Derosa, Angela Gernone, et al.
Plos One|November 14, 2019
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approachAlessio Bruni, Niccolò Giaj-Levra, Patrizia Ciammella, et al.
Tumori|July 14, 2015
Oral chemotherapy and patient perspective in solid tumors: a national survey by the Italian association of medical oncologyGaetano Aurilio, Stefania Gori, Franco Nolè, et al.
Epilepsy & Behavior : E&B|February 8, 2018
An objective score to identify psychogenic seizures based on age of onset and historyWesley T Kerr, Emily A Janio, Chelsea T Braesch, et al.
Expert Review of Anticancer Therapy|April 5, 2023
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?Matilde Corianò, Diana Giannarelli, Giulia Scartabellati, et al.
AAPS Pharmscitech|November 18, 2020
Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo StudyFatma I Abo El-Ela, Khaled H Hussein, Hossny A El-Banna, et al.
Msphere|February 23, 2024
Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participantsPinki Dash, Al Hakim, Aklima Akter, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO NetworkGiuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2022
Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinomaGuru P Sonpavde, Cora N Sternberg, Yohann Loriot, et al.
Pageof 100